- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Medical Bulletin 08/June/2026 - Video
Overview
Here are the top medical news for today:
Experts Say Cardio-Strength Combination Maximizes Health and Performance
A few hours in the gym each week may not be necessary to live longer. New research suggests that a moderate amount of strength training, especially when paired with aerobic exercise, offers the greatest protection against premature death.
Published in the British Journal of Sports Medicine, the study followed more than 147,000 U.S. adults for up to 30 years to examine how resistance training and aerobic activity influence the risk of dying from all causes, as well as from heart disease, cancer, and neurological conditions.
Researchers found that people who performed 90 to 119 minutes of resistance training per week had the lowest overall mortality risk. Compared with those who did no strength training, they were 13% less likely to die from any cause and 19% less likely to die from heart disease. The same amount of resistance training was also linked to a 27% lower risk of death from neurological diseases.
Interestingly, more was not necessarily better. Participants who performed over 120 minutes of resistance training per week did not experience additional survival benefits, suggesting a potential plateau in the protective effects of strength training.
The study also found that aerobic exercise remained a powerful predictor of longevity. People who met recommended aerobic activity guidelines experienced substantially lower mortality risks than those who did not. However, the greatest benefits were seen among individuals who combined regular aerobic exercise with moderate resistance training.
Those who engaged in both forms of exercise had the lowest risk of death from all causes, including cardiovascular disease, cancer, and neurological disorders. Even participants who performed some resistance training but little aerobic activity saw modest health benefits compared with completely inactive individuals.
The findings support current exercise guidelines that recommend combining aerobic activity with muscle-strengthening exercises. Rather than spending endless hours lifting weights, the research suggests that about 90 to 120 minutes of strength training per week, alongside regular aerobic exercise, may be the sweet spot for long-term health and longevity.
REFERENCE: Zhang Y, et al. (2026). Long-term resistance training with all-cause and cause-specific mortality: assessing dose-response and joint associations with aerobic physical activity. British Journal of Sports Medicine. DOI: 10.1136/bjsports-2025-110503. https://bjsm.bmj.com/content/early/2026/05/28/bjsports-2025-110503
Brain Imaging Study Identifies Two Distinct Biological Forms of Autism
Autism may not be a single condition with one underlying biology. A major international study has found evidence for at least two distinct brain-based autism subtypes, each marked by a different pattern of communication between brain regions.
Published in Nature Neuroscience, the research analyzed brain imaging data from 940 children and young adults with autism and compared it with scans from more than 1,000 neurotypical individuals. Scientists also examined 20 different mouse models to investigate the biological mechanisms behind these brain patterns.
The study identified two consistent autism subtypes. One group showed reduced communication between brain regions, known as hypoconnectivity, while the other displayed increased communication, or hyperconnectivity. Together, these two subtypes accounted for about one-quarter of the autistic individuals included in the research.
Researchers found that each subtype appeared to be linked to different biological processes. The hypoconnectivity pattern was associated with genes involved in synapses, the structures that allow nerve cells to communicate. In contrast, the hyperconnectivity subtype was linked to immune-related biological pathways.
To uncover these connections, scientists first identified brain connectivity signatures in mouse models and then searched for the same patterns in human brain scans. The matching results across both species provided strong evidence that distinct biological mechanisms may contribute to different forms of autism.
The findings were further supported by gene expression analyses. Brain regions showing lower connectivity were enriched with synaptic genes, while regions with higher connectivity showed greater activity of immune-related genes.
Scientists say the discovery could help move autism research toward more personalized approaches to diagnosis and treatment. Rather than viewing autism as a single condition, future care strategies may be tailored to underlying biological subtypes. The researchers also believe additional autism subtypes may emerge as larger datasets and more advanced analytical tools become available.
REFERENCE: Marco Pagani, Valerio Zerbi, Silvia Gini, Filomena Grazia Alvino, Abhishek Banerjee, Andrea Barberis, M. Albert Basson, Yuri Bozzi, Alberto Galbusera, Jacob Ellegood, Michela Fagiolini, Jason P. Lerch, Michela Matteoli, Caterina Montani, Davide Pozzi, Giovanni Provenzano, Maria Luisa Scattoni, Nicole Wenderoth, Ting Xu, Michael V. Lombardo, Michael P. Milham, Adriana Di Martino, Alessandro Gozzi. Autism subtypes identified using cross-species functional connectivity analyses. Nature Neuroscience, 2026; DOI: 10.1038/s41593-026-02287-z
Scientists Discover Cancer’s Escape Strategy Could Become Its Weakness
Cancer cells often survive by hiding from the immune system. But a new study suggests that one of their most common escape tactics may actually expose a surprising weakness.
Published in Nature Immunology, the research reveals an unexpected immune mechanism that can destroy cancer cells after they lose a key protein used to evade detection. The discovery challenges a long-standing principle in immunology and could open new avenues for cancer treatment and bone marrow transplantation.
Traditionally, scientists believed that major histocompatibility complex class I (MHC I) molecules primarily interact with CD8+ "killer" T cells, while MHC class II molecules activate CD4+ "helper" T cells. This division has guided cancer immunology research for decades.
Many tumors reduce or completely lose MHC I expression to escape attacks from CD8+ T cells. While this strategy helps cancer cells avoid one branch of the immune system, the study found it creates a new vulnerability.
Using advanced genetic analyses, mouse models, and human samples, scientists discovered that cancer cells lacking MHC I became more susceptible to attacks from CD4+ T cells. These immune cells triggered ferroptosis, a specialized form of cell death caused by iron-dependent oxidative damage.
In essence, cancer cells that evade traditional immune surveillance may inadvertently make themselves easier targets for a different immune response.
Similar immune-driven ferroptosis was observed in models of graft-versus-host disease, a potentially serious complication that can occur after bone marrow transplantation.
The discovery suggests that MHC I does more than simply guide killer T-cell responses. It may also influence how vulnerable cancer cells and other tissues are to destruction by helper T cells.
While more research is needed, the findings raise the possibility of developing future therapies that harness CD4+ T cells to target tumors that have become resistant to conventional immune attacks. If confirmed in further studies, this approach could offer a new strategy for overcoming one of cancer's most effective survival tricks.
REFERENCE: Emma Lauder, Mahnoor Gondal, Meng-Chih Wu, Akira Yamamoto, Laure Maneix, Dongchang Zhao, Yaping Sun, Marcin Cieslik, Arul M. Chinnaiyan, Pavan Reddy. MHC class I on target cells regulates CD4 T cell-mediated immunity. Nature Immunology, 2026; 27 (5): 1000 DOI: 10.1038/s41590-026-02480-z


